Editas Medicine Inc (EDIT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

11 HURLEY ST. CAMBRIDGE, MA 02141

Editas Medicine, Inc. provides genetic engineering services. The Company offers transformative genome editing technology to create a platform for the development of potential human therapeutics. Editas Medicine operates in the United States.

Data as of 2020-05-30
Market Cap1.484 Billion Shares Outstanding54.817 Million Avg 30-day Volume882.549 Thousand
P/E Ratio Dividend Yield EPS-2.77
Price/Sales61.356 Price cash flow ratio616.4 Price free cash flow ratio-20.4
Book Value4.28 Price to Tangible Book6.38 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low34.37 / 14.01 Stddev
View SEC Filings from EDIT instead.

View recent insider trading info

Funds Holding EDIT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EDIT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

151 total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BITTERMAN KEVIN

  • Director
0 2020-06-01 0

GLUCKSMANN ALEXANDRA

0 2020-05-29 0

HACK ANDREW A. F.

  • Director
0 2020-05-28 0

HOPFIELD JESSICA

  • Director
22,877 2020-05-28 1

SCADDEN DAVID

  • Director
3,849 2020-05-28 0

MULLEN JAMES C

  • Director
1,290 2020-05-20 1

ALBRIGHT CHARLES EVP/CHIEF SCIENTIFIC OFFICER

  • Officer
31,373 2020-05-06 3

MENDLEIN JOHN

  • Director
0 2020-05-01 0

HIRSCH ANDREW CHIEF FINANCIAL OFFICER

  • Officer
24,272 2020-04-22 1

VAISHNAW AKSHAY PRESIDENT, R&D

  • Officer
14,634 2020-04-20 1

BORISY ALEXIS

  • Director
0 2020-02-12 0

COLLINS CYNTHIA CEO

  • Officer
  • Director
46,998 2020-02-06 5

ROBERTSON MICHELLE CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-09 2

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

AFEYAN NOUBAR

KANIA EDWIN M JR

  • Director
  • 10% Owner
170,629,740 2019-12-09 0

ABRAMS JUDITH R CHIEF MEDICAL OFFICER

  • Officer
25,000 2019-10-28 2

BOSLEY KATRINE

  • Director
0 2019-07-18 0

STARR KEVIN P

0 2019-06-05 0

COLE DOUGLAS G.

  • Director
0 2019-05-30 0

MYER VICKESH CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-03-18 0

EK ERIC INTERIM CFO

  • Officer
0 2019-03-01 0

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES LP

VIKING GLOBAL EQUITIES II LP

VGE III PORTFOLIO LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

  • 10% Owner
22,703,669 2018-10-01 0

NIKOLIC BORIS

  • Director
0 2018-06-15 0

POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.

POLARIS VENTURE PARTNERS VI, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND VI, L.P.

  • 10% Owner
12,172,819 2018-05-29 0

FLYNN JAMES E

DEERFIELD MGMT HIF, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • Director
  • 10% Owner
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
0 2018-03-27 0

COX GERALD FRANK CHIEF MEDICAL OFFICER

  • Officer
0 2018-02-07 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SUNDHEIM DANIEL S.

  • 10% Owner
37,231,342 2016-10-26 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
3,906,176 2016-08-16 0

BNG0, LLC

  • 10% Owner
No longer subject to file 2016-02-08 0

ZHANG FENG

  • 10% Owner
480,769 2016-02-02 0

LIU DAVID R.

  • 10% Owner
480,769 2016-02-02 0

JOUNG J. KEITH

  • 10% Owner
480,769 2016-02-02 0

CHURCH GEORGE

  • 10% Owner
480,769 2016-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ALBRIGHT CHARLES - Officer EVP/CHIEF SCIENTIFIC OFFICER

2020-05-06 S 151 $25.28 d 31,373 31,373.00 direct

Elevate your investments